Abstract
As heart disease is known to be one of the leading cause of human death, t-PA(tissue-type plasminogen activator) has been received great attention as a promising thrombolytic agent and also as one of the first commercial products via the recombinant DNA-technology. Breaking up blood clot is the essential treatment of restoring the normal flow of blood in the acute myocardial infarction cases [1]. Thrombolytic agents activates plasminogen to form plasmin, which dissolves fibrin-the main component of blood clots. Plasminogen is a pro-enzyme that naturally exists in blood as free form and/or plasminogen-fibrin complex by binding to blood clots, more specifically fibrin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chien K, Meidell R, Gerard R (1987) Tissue plasminogen activator: From molecular biology to myocardial infarction. Amer. J. of Med. Sci., 292, 201–207.
Geiger M, Binder B (1987) Tissue-type plasminogen activator and urokinase: Differences in the reaction pattern with active-site titrant 4-methyumbelliferyl-p guanidinobenzoate hydrochloride. Biochimica Biophysica Acta, 912, 34–40
Kretzmer G, Scrugerl K (1991) Response of mammalian cells to shear stress. Appl Microbiol Biotechnol, 34, 613–616.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Tokyo
About this paper
Cite this paper
Cho, G.H., Kim, Y.J. (1992). Production of t-PA by Recombinant Mouse Fibroblast Cell Cultures in a Perfusion Bioreactor. In: Furusaki, S., Endo, I., Matsuno, R. (eds) Biochemical Engineering for 2001. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68180-9_88
Download citation
DOI: https://doi.org/10.1007/978-4-431-68180-9_88
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68182-3
Online ISBN: 978-4-431-68180-9
eBook Packages: Springer Book Archive